Biosimilars

book edition published in 2017

mentions

First seen: há 4 mesesLast seen: há 13 dias

wikidata

Recent News4

permanente.org·há 15 dias

How Permanente Medicine is helping unlock the promise of biosimilars

Maisha Draves, MD, MPH, explains the potential of biosimilars in health care to expand access, improve affordability, and create better outcomes. The post How Permanente Medicine is helping unlock the

benefitscanada.com·há 3 meses

Generic Ozempic could trim employer drug costs, but savings depend on plan design: expert

Health Canada has approved two generic versions of glucagon-like peptide-1 receptor agonist medication Ozempic, a move that could ease cost pressures for employer-sponsored benefits plans. The introdu

benefitscanada.com·há 4 meses

High-cost, weight management drugs reshaping Canada’s private drug plans: report

A new generation of ultra-high-cost therapies is reshaping benefits plan risk, while the arrival of generic glucagon-like peptide-1 receptor agonist medications is set to shift one of the largest drug

benefitscanada.com·há 4 meses

Weight management drugs, rare disease treatments expected to drive private drug plan costs in 2026: report

Weight management drugs and high-cost specialty treatments are expected to have the biggest impact on private drug plans this year, according to Telus Health’s annual drug pipeline report. It fo

Related Entities

1Drug Plan Design61×
2Benefits61×
3Health Benefits61×
4Glp-1 Drugs43×
5Benefits Canada News43×
6Drug Plans43×
7Generic Drugs42×
8Health/Wellness42×
9Obesity42×
10Pharmacare37×

Biosimilars — Entidade | Buobe